| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.3 | 6e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.31 | 9e-08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.07 | 0.2 |